Kernal has been awarded up to $48M funding to accelerate the development of KR-402, a next-generation in vivo CAR T-cell ...
The team used human stem cells to create embryo-like structures dubbed “hematoids” that mirror some features of early human ...
Sana Biotechnology, Inc. is a Strong Buy with promising cell therapies for diabetes & B-cell disorders. Click here to find ...
University of Cambridge scientists have used human stem cells to create three-dimensional embryo-like structures that ...
Nutrition experts share the best time to take vitamin B, plus who should be supplementing, how much you need, and what all ...
The embryo-like model could help scientists test new drugs, create stem cells for transplants and research blood disorders ...
Bayer AG has struck a deal with Atara Biotherapeutics to jointly work on Atara's CAR-T cell anti-tumour treatments, as the German group firms up its commitment to build a specialist cell and gene ...
Developing cardiac inflammatory organoid models incorporating multiple cell lineages is vital for novel therapies.
MIT and Harvard scientists have designed an advanced type of immune cell called a CAR-NK cell that can destroy cancer while ...
Scientists have long suspected connections between heredity and disease, dating back to Hippocrates, who observed certain ...
Upcoming safety data release expected to also highlight favorable tolerability profile observed to date and ease-of-use of the regimen that includes cyclophosphamide/fludarabine conditioning, and ...
News-Medical.Net on MSN
How shifting antibodies fuel aging and the new therapies aiming to slow it
This review uncovers how aging reshapes immunoglobulins, particularly IgG, IgM, and IgA, driving inflammation, cellular senescence, and tissue degeneration. By dissecting B-cell dysfunction, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results